The Michael J. Fox Foundation Annual Report 2018 Impact + Innovation | Page 23

2018 Annual Report
Industry
Partners
The Michael J. Fox Foundation engages
pharmaceutical and biotechnology companies to
enhance our programs through research funding,
sponsorships, in-kind contributions, strategic input
and more. Thanks to these industry partners for
contributing more than $6 million in 2018 to our
mission to speed a cure.
23andMe
Abbott
AbbVie
Abcam
Acadia Pharmaceuticals
Accenture
Acorda Therapeutics
Adamas Pharmaceuticals
Allergan
Amicus Therapeutics
Arvinas
AstraZeneca Pharmaceuticals
ATTC
Biogen
Boston Scientific
Celgene Corporation
Charles River Laboratories
Denali Therapeutics
GE Healthcare
GlaxoSmithKline
Google
IBM Corporation
Intec Pharma
Lundbeck
Medtronic
Merck & Company
Novartis
Pfizer
Pharmaceutical Research and
Manufacturers of America (PhRMA)
Prevail Therapeutics
Prothena Biosciences
Regeneron Pharmaceuticals
Roche
Sanofi
StressMarq
Sunovion Pharmaceuticals
Takeda Pharmaceuticals International
UCB
United Technologies
Verily
Voyager Therapeutics
Visit michaeljfox.org/sponsors to learn about sponsorship opportunities.
21